| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/21/2007 | EP1754783A1 Transfected hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
| 02/21/2007 | EP1754718A2 Inactivation resistant factor VIII |
| 02/21/2007 | EP1754488A1 Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases |
| 02/21/2007 | EP1753478A1 Medical device comprising a biologically active agent |
| 02/21/2007 | EP1753464A2 Annexin ii and uses thereof |
| 02/21/2007 | EP1753292A2 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF PRIMATE POLYOMAVIRUS GENES |
| 02/21/2007 | EP1592702A4 Beta-2 microglobulin (b2m) and b2m related gene products for the regulation of osteoarthritis pathogenesis and chondrocyte proliferation |
| 02/21/2007 | EP1581053A4 Expression of zeta negative and zeta positive nucleic acids using a dystrophin gene |
| 02/21/2007 | EP1328254B1 Lipid formulations for target delivery |
| 02/21/2007 | EP1232177B1 Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides |
| 02/21/2007 | EP1161524B1 CELLS COEXPRESSING AN AMYLOID PRECURSOR PROTEIN AND AN $g(a)-SECRETASE AND THEIR USES IN TEST METHODS AND DIAGNOSTICS |
| 02/21/2007 | EP1086225B1 Human tumour-derived polypeptide hormone phosphatonin |
| 02/21/2007 | EP0988373B1 Selection marker |
| 02/21/2007 | EP0954334B1 Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy |
| 02/21/2007 | EP0815202B1 Human tissue inhibitor of metalloproteinase-4 |
| 02/21/2007 | CN1918293A Substituted non-coding nucleic acid molecule for therapeutic or prophylaxis immunological stimulus for human and higher animal |
| 02/21/2007 | CN1918292A Oligomeric compounds for the modulation of bcl-2 |
| 02/21/2007 | CN1918284A Stem cells |
| 02/21/2007 | CN1918175A Oligonucleotide compositions and methods for treating disease including inflammatory conditions |
| 02/21/2007 | CN1917902A Use for interleukin-33 (il-33) and the il-33 receptor complex |
| 02/21/2007 | CN1917897A Composition and methods for modulating cns activity |
| 02/21/2007 | CN1916174A siRNA sequence of idiosyncratic silent nm23óÄ1, and carrier and application |
| 02/21/2007 | CN1916167A Modulation of peroxisome proliferation-activated receptors |
| 02/21/2007 | CN1915968A Neutral-cationic lipid for nucleic acid and drug delivery |
| 02/21/2007 | CN1915433A Relativity between AnnexinA3 and drug resistance of platinum type chemical curing medication for cancer |
| 02/21/2007 | CN1915432A Gene medication in use for treating tumor from epithelium, and preparation method |
| 02/21/2007 | CN1915425A Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| 02/21/2007 | CN1301329C Tumour cell specific eucaryon expressing carriers |
| 02/21/2007 | CN1301263C Nucleotide sequence for anti HIV infection and preventing AIDS and use thereof |
| 02/21/2007 | CN1301131C Viral myocarditis gene vaccine, its preparation method and application |
| 02/20/2007 | US7179903 Liver specific transcriptional enhancer |
| 02/20/2007 | US7179901 Renal regulatory elements and methods of use thereof |
| 02/20/2007 | US7179797 Methods and compositions for treating prostate cancer using DNA vaccines |
| 02/20/2007 | US7179796 Protein phosphatase 1B; oligonucleotide of 8-50 nucleobases targeted to a nucleic acid molecule encoding PTP1B; specifically hybridizes with and inhibits the expression of PTP1B. |
| 02/20/2007 | US7179795 Nucleic acids encoding chimeric proteins comprising BMP-2 and a proteinase inhibitor |
| 02/20/2007 | US7179784 Surfactant peptide nanostructures, and uses thereof |
| 02/20/2007 | US7179649 Culturing adipose stromal cells in a medium capable of supporting the growth of fibroblasts and differentiation inducing amounts of beta - glycerophosphate and ascorbic acid and/or ascorbic-2 phosphate |
| 02/20/2007 | US7179646 Useful for obtaining tumour-selective gene expression in tumours having a mutated beta -catenin pathway; used to express genes encoding therapeutic proteins in colorectal cancer cells |
| 02/20/2007 | US7179608 Therapeutic antiangiogenic compositions and methods |
| 02/20/2007 | US7179472 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 02/20/2007 | US7179467 DCMP2 polypeptide |
| 02/20/2007 | US7179459 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases |
| 02/20/2007 | US7179458 Lactobacilli expressing biologically active polypeptides and uses thereof |
| 02/20/2007 | US7179457 Modified to include heterologous insertion downstream of its replicase open reading frames; insertion preferably comprises one or more protein-coding regions ideal for virus-like particles packaging |
| 02/20/2007 | CA2289979C Methods of modulating immune coagulation |
| 02/15/2007 | WO2007019406A2 Methods for treating and detecting beta-cell disease |
| 02/15/2007 | WO2007019190A2 Role of gax in alzheimer neurovascular dysfunction |
| 02/15/2007 | WO2007019107A2 Adipose tissue stem cells, perivascular cells and pericytes |
| 02/15/2007 | WO2007018437A1 Methods of modulating apoptosis and platelet production using variants of cytochrome c |
| 02/15/2007 | WO2007018318A1 Method for gene expression specific to cerebellar astrocyte and/or basket cell |
| 02/15/2007 | WO2007018316A1 Prophylactic/therapeutic agent for cancer |
| 02/15/2007 | WO2007018229A1 Treatment of adult t-cell leukemia |
| 02/15/2007 | WO2007018143A1 Use of gene which varies in amount of expression during the course of transition from precancer to cancer |
| 02/15/2007 | WO2007018047A1 Squamous cell carcinoma antigen-derived peptide binding to hla-a24 molecule |
| 02/15/2007 | WO2007017915A2 Use of common ϝ chain cytokines for the visualization, isolation and genetic modification of memory t lymphocytes. |
| 02/15/2007 | WO2007017212A2 Use of an active biological substance in abnormal cellular and viral membrane physiologies |
| 02/15/2007 | WO2007016764A1 Composition and method for prevention and treatment of type i diabetes |
| 02/15/2007 | WO2006133022A9 Compositions and methods for decreasing microrna expression for the treatment of neoplasia |
| 02/15/2007 | WO2006127976A3 Compositions and their uses directed to ptpru |
| 02/15/2007 | WO2006119458A9 Gene therapy for neurometabolic disorders |
| 02/15/2007 | WO2006115547A8 Dendritic polymers with enhanced amplification and interior functionality |
| 02/15/2007 | WO2006106521A8 Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules |
| 02/15/2007 | WO2006099615A3 Adenoviral fiber exchange shuttle system |
| 02/15/2007 | WO2006063009A3 Diagnosis of hyperinsulinemia and type ii diabetes and protection against same based on proteins differentially expressed in serum |
| 02/15/2007 | WO2005067583A3 Immunoliposome-nucleic acid amplication (ilnaa) assay |
| 02/15/2007 | WO2005013904A3 Sars nucleic acids, proteins, vaccines, and uses thereof |
| 02/15/2007 | US20070039072 Functional and hyperfunctional siRNA |
| 02/15/2007 | US20070037770 Oligonucleotide N3'-P5' thiophosphoramidates: their synthesis and use |
| 02/15/2007 | US20070037769 Compositions and methods to treat and control tumors by loading antigen presenting cells |
| 02/15/2007 | US20070037768 Methods for therapy of neurodegenerative disease of the brain |
| 02/15/2007 | US20070037767 Immunostimulatory nucleic acids for the treatment of asthma and allergy |
| 02/15/2007 | US20070037766 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 02/15/2007 | US20070037765 gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 02/15/2007 | US20070037764 Method and antisense composition for selective inhibition of HIV infection in hematopoietic cells |
| 02/15/2007 | US20070037763 Oligonucleotide compound and method for treating nidovirus infections |
| 02/15/2007 | US20070037762 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOGENESIS |
| 02/15/2007 | US20070037761 Gene expression inhibition using small interfering RNAs which are specific for the vascular endothelial growth factor (VEGF) gene and the VEGF receptor genes Flt-1 and Flk-1/KDR; diabetic retinopathy, age related macular degeneration and many types of cancer |
| 02/15/2007 | US20070037760 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOGENESIS |
| 02/15/2007 | US20070037759 Mammalian retrotransposable elements |
| 02/15/2007 | US20070037741 Novel compositions and methods for the treatment of immune related disease |
| 02/15/2007 | US20070037269 Mutants of desoxycytidine kinase having extended enzymatic activity |
| 02/15/2007 | US20070037256 Determining whether a DNA sequence comprises a gene transcription modulating quality and/or a gene transcription repressing quality; systematic elucidation and identification of regulatory sequences |
| 02/15/2007 | US20070037218 Human gene critical to fertility |
| 02/15/2007 | US20070037203 Novel 21910, 56634, 55053, 2504, 15977, 14760, 25501, 17903, 3700, 21529, 26176, 26343, 56638, 18610, 33217, 21967, H1983, M1983, 38555 or 593 molecules and uses therefor |
| 02/15/2007 | US20070037158 Methods of modulating bone growth, bone remodeling and adiposity |
| 02/15/2007 | US20070037147 Endogenous retrovirus polypeptides linked to oncogenic transformation |
| 02/15/2007 | US20070036867 Controlled and Sustained Gene Transfer Mediated by Thiol-Modified Polymers |
| 02/15/2007 | US20070036866 Cationic block copolymers |
| 02/15/2007 | US20070036865 Endosomolytic Polymers |
| 02/15/2007 | US20070036824 Optimized expression of hpv 58 l1 in yeast |
| 02/15/2007 | US20070036813 Expression vector comprising nucleotide sequences coding endothelial growth factor protein for use in prevention and treatment of cell proliferative and eye disorders |
| 02/15/2007 | US20070036807 freezing dried biochemical conjugated immunomodulator comprising immunostimulatory polynucleotide sequence and plant Ragweed allergen; genetic vaccines |
| 02/15/2007 | US20070036794 Agonist anti-trkC monoclonal antibodies, directed against epitopes in extracellular domain of trkC receptor, which mimic biological activities of NT-3, the natural ligand of trkC receptor, but are free of some of known detriments of NT-3; use of theseagonist antibodies treatment of neuropathy |
| 02/15/2007 | US20070036787 Insulin-induced gene as therapeutic target in diabetes |
| 02/15/2007 | US20070036778 Staphylococcus; immunogens; immumostimulatory sequences; cationic peptides |
| 02/15/2007 | US20070036775 Method of modulating or examining Ku70 levels in cells |
| 02/15/2007 | US20070036774 Liver engrafting cells, assays, and uses thereof |
| 02/15/2007 | US20070036773 Generation and application of universal T cells for B-ALL |
| 02/15/2007 | US20070036772 Directed in vitro differentiation of marrow stromal cells into neural cell progenitors |
| 02/15/2007 | US20070036771 Biologic device for regulation of gene expression and method therefor |